1.Therapeutic Targeting of CXCL10 and TNF-α: Since CXCL10 and TNF-α play significant roles in promoting neuroinflammation and disease progression, targeted therapies aimed at modulating these cytokines may improve outcomes in African trypanosomiasis. The gene discussed is CXCL10; the disease is human African trypanosomiasis.